Cash & equivalents increased 87.2%
Cash & equivalents changed +87.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +87.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed +69.0% from the comparable as-filed period.
Gross margin changed +632 basis points from the comparable as-filed period.
Operating margin changed +1728 basis points from the comparable as-filed period.
Net income changed +77.6% from the comparable as-filed period.
Inventory / revenue changed -15423 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +25.4% from the comparable as-filed period.
Gross profit changed +42.4% from the comparable as-filed period.
Operating margin changed -743 basis points from the comparable as-filed period.
Gross margin changed -368 basis points from the comparable as-filed period.
Cash & equivalents changed -39.1% from the comparable as-filed period.
Research & development changed -31.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.